To Study the Pathophysiological Features of Multiple Sclerosis
NCT04242056
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Neurofilament Light Chain
Glial Fibrillary Acidic Protein
Interventions
DRUG:
18F-PM-PBB3
Sponsor
Chang Gung Memorial Hospital